Email updates

Keep up to date with the latest news and content from BMC Research Notes and BioMed Central.

Open Access Highly Accessed Short Report

Cognitive behavioral therapy for depression among adults in Japanese clinical settings: a single-group study

Daisuke Fujisawa12*, Atsuo Nakagawa1, Miyuki Tajima3, Mitsuhiro Sado1, Toshiaki Kikuchi1, Motomi Hanaoka4 and Yutaka Ono5

Author Affiliations

1 Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

2 Psycho-Oncology Division, National Cancer Center East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba, Japan

3 Stress Management Office, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo Japan

4 Department of Neuropsychiatry, Tokyo Women's University School of Medicine, 8-1Kawatacho, Shinjuku-ku, Tokyo, Japan

5 Health Management Center, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo Japan

For all author emails, please log on.

BMC Research Notes 2010, 3:160  doi:10.1186/1756-0500-3-160

Published: 7 June 2010



Empirical support for cognitive behavioral therapy (CBT) for treating Japanese patients with major depression is lacking, therefore, a feasibility study of CBT for depression in Japanese clinical settings is urgently required.


A culturally adapted, 16-week manualized individual CBT program for Japanese patients with major depressive disorder was developed. A total of 27 patients with major depression were enrolled in a single-group study with the purpose of testing the feasibility of the program. Twenty six patients (96%) completed the study. The mean total score on the Beck Depression Inventory-II (BDI-II) for all patients (Intention-to-treat sample) improved from 32.6 to 11.7, with a mean change of 20.8 (95% confidence interval: 17.0 to 24.8). Within-group effect size at the endpoint assessment was 2.64 (Cohen's d). Twenty-one patients (77.7%) showed treatment response and 17 patients (63.0%) achieved remission at the end of the program. Significant improvement was observed in measurement of subjective and objective depression severity (assessed by BDI-II, Quick Inventory of Depressive Symptomatology-Self Rated, and Hamilton Depression Rating Scale), dysfunctional attitude (assessed by Dysfunctional Attitude Scale), global functioning (assessed by Global Assessment of Functioning of DSM-IV) and subjective well-being (assessed by WHO Subjective Well-being Inventory) (all p values < 0.001).


Our manualized treatment comprised of a 16-week individual CBT program for major depression appears feasible and may achieve favorable treatment outcomes among Japanese patients with major depression. Further research involving a larger sample in a randomized, controlled trial design is warranted.

Trial registration

UMIN-CTR UMIN000002542.